Reuters: Regulatory News: UPDATE 1-St. Jude wins European OK for brain implant to treat Dystonia

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-St. Jude wins European OK for brain implant to treat Dystonia Apr 10th 2013, 12:47 Wed Apr 10, 2013 8:47am EDT April 10 (Reuters) - St. Jude Medical Inc said on Wednesday it received European regulatory approval for a brain implant used to treat primary and secondary Dystonia, a neurological movement disorder. The maker of heart pacemakers, valves and other medical devices said European regulators approved its Brio, Kibra and LibraXP deep brain stimulation systems for managing symptoms of the incurable disease. Dystonia causes a person's muscles to involuntarily contract and spasm, and can leave its victims wheelchair-bound. For those who do not respond to medication, deep brain stimulation may help manage symptoms. The device works by delivering electrical pulses to specific areas of the brain involved in controlling movement. Dystonia is thought to affect more than 500,000 people in Europe. Primary dystonia may be genetically inherited; the origin of the disorder is unknown. Secondary dystonia is considered environmental or symptomatic. It may result from a condition such as a stroke, or be a response to certain medications.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions